Innovative and Best-In-Breed DNA Technology Overcomes Challenges in the Drug Development
The global effects that have been brought on by the COVID-19 pandemic underscores the criticality of being able to get drugs to developed and to the market as quickly as possible, while not compromising standard quality and safety criteria.
Alongside the acceleration of vaccine development seen in response to the COVID-19 pandemic, cell and gene therapies have shown huge advances over the past decade with several methods already in mainstream use (gene editing, CAR-T, and AAV). A look at the history and potential future of therapeutics in these areas further highlights the importance of genetic engineering in the drug development process.
White paper is focusing on Innovative DNA Technology Overcomes Challenges in the Drug Development